Artículos por temáticas

The role of magnetic fields in neurodegenerative diseases

Riancho J, Sanchez de la Torre JR, Paz-Fajardo L, Limia C, Santurtun A, Cifra M, Kourtidis K, Fdez-Arroyabe P.

Int J Biometeorol. 2021 Jan;65(1):107-117. doi: 10.1007/s00484-020-01896-y. Epub 2020 Mar 20.

Glutamatergic inputs to GABAergic interneurons in the motor thalamus of control and parkinsonian monkeys

Albaugh DL, Huang C, Ye S, Paré JF, Smith Y.

Eur J Neurosci. 2021 Apr;53(7):2049-2060. doi: 10.1111/ejn.14763. Epub 2020 May 16.

Application of Nanomaterials in Neurodegenerative Diseases

Cui W, Fu W, Lin Y, Zhang T.

Curr Stem Cell Res Ther. 2021;16(1):83-94. doi: 10.2174/1574888X15666200326093410.

Voluntary movements cause beta oscillations increase and broadband slope decrease in the subthalamic nucleus of parkinsonian patients

Belova EM, Semenova U, Gamaleya AA, Tomskiy AA, Sedov A.

Eur J Neurosci. 2021 Apr;53(7):2205-2213. doi: 10.1111/ejn.14715. Epub 2020 Mar 20.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of Parkinsonism

Abdelwahab S, Elsebay SAG, Fouli Gaber M, Abdel-Hafez SMN.

J Cell Physiol. 2021 Jan;236(1):440-457. doi: 10.1002/jcp.29872. Epub 2020 Jun 17.

Anticholinergic Medications

Ghossein N, Kang M, Lakhkar AD.

2021 May 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.

Effect of different types of exercises on psychological and cognitive features in people with Parkinson's disease: A randomized controlled trial

Gobbi LTB, Pelicioni PHS, Lahr J, Lirani-Silva E, Teixeira-Arroyo C, Santos PCRD.

Ann Phys Rehabil Med. 2021 Jan;64(1):101407. doi: 10.1016/j.rehab.2020.05.011. Epub 2020 Oct 6.

Altered white matter microarchitecture in Parkinson's disease: a voxel-based meta-analysis of diffusion tensor imaging studies

Suo X, Lei D, Li W, Li L, Dai J, Wang S, Li N, Cheng L, Peng R, Kemp GJ, Gong Q.

Front Med. 2021 Feb;15(1):125-138. doi: 10.1007/s11684-019-0725-5. Epub 2020 May 26.

Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases

Gao J, Liao Y, Qiu M, Shen W.

Neuroscientist. 2021 Feb;27(1):58-72. doi: 10.1177/1073858420914509. Epub 2020 Apr 3.

Finger tapping as a proxy for gait: Similar effects on movement variability during external and self-generated cueing in people with Parkinson's disease and healthy older adults

Horin AP, Harrison EC, Rawson KS, Earhart GM.

Ann Phys Rehabil Med. 2021 Jul;64(4):101402. doi: 10.1016/j.rehab.2020.05.009. Epub 2020 Jul 20.

Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease

Abraham DS, Pham Nguyen TP, Hennessy S, Gray SL, Xie D, Weintraub D, Willis AW.

Am J Geriatr Psychiatry. 2021 Jan;29(1):35-47. doi: 10.1016/j.jagp.2020.05.014. Epub 2020 May 18.

Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors

Mohammadi S, Dolatshahi M, Rahmani F.

J Endocrinol Invest. 2021 Jan;44(1):1-13. doi: 10.1007/s40618-020-01314-5. Epub 2020 Jun 4.

Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci

Smeland OB, Shadrin A, Bahrami S, Broce I, Tesli M, Frei O, Wirgenes KV, O'Connell KS, Krull F, Bettella F, Steen NE, Sugrue L, Wang Y, Svenningsson P, Sharma M, Pihlstrøm L, Toft M, O'Donovan M, Djur

Biol Psychiatry. 2021 Feb 1;89(3):227-235. doi: 10.1016/j.biopsych.2020.01.026. Epub 2020 Feb 8.

Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease

Mathew GE, Oh JM, Mohan K, Tengli A, Mathew B, Kim H.

J Biomol Struct Dyn. 2021 Aug;39(13):4786-4794. doi: 10.1080/07391102.2020.1782266. Epub 2020 Jun 26.